Evidence mapPaperPMID 40728653Full record

ArticleOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025

Incidence of hip fractures in persons with and without Parkinson's disease in Finland: a 15-year longitudinal study.

Miriam T Y Leung, Marja-Leena Lamidi, Sirpa Hartikainen, Blair Rajamaki, J Simon Bell, Justin P Turner, Anna-Maija Tolppanen

Abstract read
In one paragraph

Article in Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Comment on - Bisphosphonate use is associated with reduced fracture rates in a cohort of patients with Parkinson's disease: clinical caveats beyond a one-year claims analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miriam T Y LeungCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, (Parkville Campus), 381 Royal Parade, Parkville Victoria, 3052, Australia. miriam.leung77@monash.edu.ORCID http://orcid.org/0000-0002-4259-7058
Marja-Leena LamidiSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Sirpa HartikainenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
Blair RajamakiSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.
J Simon BellCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, (Parkville Campus), 381 Royal Parade, Parkville Victoria, 3052, Australia.
Justin P TurnerCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, (Parkville Campus), 381 Royal Parade, Parkville Victoria, 3052, Australia.
Anna-Maija TolppanenSchool of Pharmacy, University of Eastern Finland, Kuopio, Finland.

Funding

Australian Government Australian Government Research Training Scholarship
6 · The paper itself

Abstract

Despite growing evidence on prodromal symptoms of Parkinson's disease, it remains unknown whether they culminated in clinically significant events. We found elevated risks of hip fractures from 3 years before until up to 10 years after diagnosis of Parkinson's disease, underscoring the need for early and continuous fracture risk management. PURPOSE: Parkinson's disease (PD) is associated with a higher risk of hip fracture. However, the risk of hip fracture at the prodromal stage of PD is unknown. Our study aimed to investigate the incidence of hip fractures in persons with and without PD in Finland from 5 years before to 10 years after the diagnosis of PD.

methodsWe included persons diagnosed with PD between 2000 and 2009 in Finland and 1:2 matched comparison cohort. Hazard ratio [HR] was computed to assess overall risk of incident hip fracture. The annual incidence rate per 1000 person-year [IR/1000PY] and incidence rate ratios [IRR] were calculated for each year of follow-up from 5 years before to 10 years after PD diagnosis.

resultsDuring the follow-up among 33,153 eligible persons, 13.4% persons with and 5.3% persons without PD had an incident hip fracture (HR 1.82, 95% confidence interval [CI] 1.47-2.26). Persons with PD had higher annual incidence rates of hip fracture starting from 3 years before diagnosis (with PD: IR/1000PY 2.83, 95% CI 1.93-4.02; without PD: IR/1000PY 1.64, 95% CI 1.15-2.28). The higher annual incidence rates continued until 10 years after diagnosis (with PD: IR/1000PY 15.7, 95% CI 11.7-20.5; without PD: IR/1000PY 4.53, 95% CI 3.08-6.44). Prevalence of fall-risk-increasing medications but not anti-osteoporosis medications was higher at hip fractures among persons with PD than without PD.

conclusionAs the risk of hip fracture is elevated already years before the diagnosis of PD, it is important to manage fall risks concomitantly while applying the diagnostic procedures for PD.

Indexed as

Hip FracturesOsteoporotic FracturesParkinson DiseaseAgedAged, 80 and overCase-Control StudiesFemaleFinlandHumansIncidenceLongitudinal StudiesMaleMiddle AgedProdromal SymptomsRisk AssessmentRisk FactorsAntiresorptive medicationFall-risk-increasing medicationsHip fractureParkinson’s disease

Identifiers

PMID40728653
PMCPMC12460458

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.